CRMAX
Price
$10.43
Change
-$0.22 (-2.07%)
Updated
Feb 21 closing price
Net Assets
173.19M
VEXAX
Price
$144.57
Change
-$4.57 (-3.06%)
Updated
Feb 21 closing price
Net Assets
116.7B
Ad is loading...

CRMAX vs VEXAX

Header iconCRMAX vs VEXAX Comparison
Open Charts CRMAX vs VEXAXBanner chart's image
CRM Small/Mid Cap Value I
Price$10.43
Change-$0.22 (-2.07%)
VolumeN/A
Net Assets173.19M
Vanguard Extended Market Index Admiral
Price$144.57
Change-$4.57 (-3.06%)
VolumeN/A
Net Assets116.7B
CRMAX vs VEXAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CRMAX vs. VEXAX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRMAX is a Hold and VEXAX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEXAX has more cash in the bank: 117B vs. CRMAX (173M). VEXAX pays higher dividends than CRMAX: VEXAX (1.20) vs CRMAX (0.59). CRMAX was incepted earlier than VEXAX: CRMAX (20 years) vs VEXAX (24 years). CRMAX is a more actively managed with annual turnover of: 42.00 vs. VEXAX (11.00). CRMAX has a lower initial minimum investment than VEXAX: CRMAX (2500) vs VEXAX (3000). VEXAX annual gain was more profitable for investors over the last year : 14.31 vs. CRMAX (-3.35). VEXAX return over 5 years is better than : 47.41 vs. CRMAX (-8.46).
CRMAXVEXAXCRMAX / VEXAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years24 years-
Gain YTD-3.6930.340-1,086%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets173M117B0%
Annual Yield % from dividends0.591.2049%
Returns for 1 year-3.3514.31-23%
Returns for 3 years-1.8721.16-9%
Returns for 5 years-8.4647.41-18%
Returns for 10 years-27.62115.96-24%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALVO12.280.58
+4.96%
Alvotech
WEST6.350.10
+1.60%
Westrock Coffee Company
LPTX0.48N/A
-0.52%
Leap Therapeutics
LPLA372.13-7.33
-1.93%
LPL Financial Holdings
OPRX5.78-0.41
-6.62%
OptimizeRx Corp